ClinicalTrials.gg
RecruitingNCT07567053Updated Oct 22, 2026

Repetitive Transcranial Magnetic Stimulation on Motor Function and Meta-Plasticity in Cerebral Palsy: TMS-EEG Study

An interventional study of MRI and HD-EEG Recording in Cerebral Palsy and Typically Developing Children, sponsored by Cook Children's Health Care System. Recruiting at 1 site in United States. Open to participants aged 6 Years to 20 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Cook Children's Health Care System · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started May 2026; still recruiting 5 months later.
Updated Oct 22, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
6 Years to 20 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 372 studies in Cerebral Palsy with a site in United States — 74 open to participants now, 102 under way, none of them phase 3. Cerebral Palsy · United States.

Planned enrollment
60th of 296
60 · median 25
Started
2026
with 23 others
No phase
218 of 372
49 open now
Primary completion
2028-05
later than 67 of 101 live
Registered
365th of 372
by date

Among the 372 studies in Cerebral Palsy with a site in United States, this one is the 60th largest by planned enrollment of the 296 interventional ones that give a count, is one of 24 that started in 2026, is one of 218 with no phase, reaches primary completion later than 67 of the 101 other live ones, and was the 365th registered.

Cerebral Palsy

1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

74 of the 372 studies in Cerebral Palsy with a site in United States are open now. Recruiting first, the newest first:

68 more — sign in →

All 74 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.

This study: 6 Years to 20 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 372 studies in Cerebral Palsy with a site in United States, or all of them as a file.
02

Study summary

This project examines the use of repetitive transcranial magnetic stimulation (rTMS) as a therapeutic approach to improve motor function in children with cerebral palsy (CP). By applying 6-Hz primed low and high-frequency rTMS and measuring brain responses through TMS-EEG, the study aims to enhance neural plasticity and motor recovery. The goal is to promote faster rehabilitation and reduce long-term healthcare needs.

Read the detailed description

Cerebral Palsy (CP) is a neurodevelopmental condition marked by motor impairments that affect both upper and lower limbs. This project investigates the therapeutic benefits, safety, and tolerability of repetitive transcranial magnetic stimulation (rTMS) for improving motor function and meta-plasticity (re-organization) in children with CP. Specifically, the study investigates the effects of 6-Hz primed low and high-frequency rTMS on neural motor function and meta-plasticity, utilizing TMS-EEG as a core method for assessing motor evoked potentials (MEPs) and TMS-evoked potentials (TEPs). Through modulating cortical excitability, the investigators expect that 6-Hz primed low and high-frequency rTMS will improve motor function and generate meta-plasticity in children with CP. This improvement in motor and induced meta-plasticity potentially leads to faster rehabilitation outcomes and reduced need for long-term care, which would benefit both patients and hospital systems by lowering treatment costs and improving resource allocation.

03

Conditions studied

  • Cerebral Palsy
  • Typically Developing Children

Browse trials for

Keywords

  • Cerebral Palsy
  • CP
  • TMS
  • repetitive Transcranial Magnetic Stimulation
  • Transcranial Magnetic Stimulation
  • rTMS
  • TMS-EEG
04

Who can participate

Ages eligible
6 Years to 20 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria (CP):

  • Aged 6 - 20 years,
  • A confirmed diagnosis of CP by a specialized professional (pediatric neurologist, PM\&R physician, neonatal developmental specialist, or neonatologist) is a prerequisite for participation,
  • Classified as high functioning (Level I, II, or III) according to the Gross Motor Function Classification System (GMFCS),
  • Age-appropriate ability to understand and comply with study procedure throughout the entire duration of the study,
  • Preserved vision and hearing (with or without correction).

Inclusion Criteria (TD):

  • Aged 6 - 20 years
  • Age-appropriate ability to understand and comply with study procedure throughout the entire duration of the study,
  • Preserved vision and hearing (with or without correction).

Exclusion Criteria (CP):

  • Syndromic or genetic brain-related associations,
  • History of major trauma or brain surgery,
  • Inability to remain still,
  • History of Epilepsy,
  • Severe coexisting sickness or illness unrelated to CP or unstable medical conditions such as pneumonia,
  • Modified Ashworth Scale: Shoulder, elbow, and wrist scores more than 3,
  • Limb contractures caused by any other injury except CP,
  • Severe movement disorders that prevent intentional limb movements, such as choreoathetosis, or ballismus,
  • for rTMS include non-removable metallic objects close to a coil and implanted electronic devices, such as cochlear implants and pacemakers.

Exclusion Criteria (TD):

  • Syndromic or genetic brain-related associations,
  • History of major trauma or brain surgery,
  • Inability to remain still,
  • History of Epilepsy,
  • Severe coexisting sickness or illness unrelated to CP or unstable medical conditions such as pneumonia,
  • Limb contractures caused by injury,
  • Severe movement disorders that prevent intentional limb movements, such as choreoathetosis, or ballismus,
  • Contraindications for rTMS include non-removable metallic objects close to a coil and implanted electronic devices, such as cochlear implants and pacemakers.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Intervention Group 1

    CP participants in the experiment intervention group 1 will receive rTMS using a figure-of-eight-shaped coil and rTMS stimulator (Nexstim, Finland) targeting the contralesional primary motor cortex. The intervention will consist of 10 sessions, each lasting 20 minutes, spread over four weeks. Each session will begin with priming: 10 minutes of 6-Hz rTMS at 90% of the resting motor threshold, delivered in two trains per minute (5 seconds per train with 25-second intervals between trains), totaling 600 priming pulses. This will be followed immediately by 10 minutes of 1-Hz rTMS at 90% of the resting motor threshold, delivered continuously without interruption, totaling 600 low-frequency pulses.

    Device: MRI · Device: HD-EEG Recording · Device: rTMS

  • Experimental
    Intervention Group 2

    CP Participants in experiment intervention group 2 will receive rTMS targeting the ipsilesional primary motor cortex. The intervention will consist of 10 sessions, each lasting 20 minutes, spread over four weeks. Each session will start with priming: 10 minutes of 6-Hz rTMS at 90% of the resting motor threshold, delivered in two trains per minute (5 seconds per train with 25-second intervals between trains), totaling 600 priming pulses. This will be followed immediately by 10 minutes of 10 Hz rTMS at 90% of the resting motor threshold, delivered continuously without interruption, totaling 2000 high-frequency pulses.

    Device: MRI · Device: HD-EEG Recording · Device: rTMS

  • Sham comparator
    Sham Group

    CP participants in the sham group will receive sham rTMS by positioning the coil perpendicular to the scalp without delivering active stimulation, targeting both the contralesional and ipsilesional primary motor cortex. The intervention will consist of 10 sessions, each lasting 20 minutes, spread over four weeks.

    Device: MRI · Device: HD-EEG Recording · Device: rTMS

  • Active comparator
    Control Group

    Typically developed control group will complete a single baseline TMS-EEG session to measure TEPs. This involves high-density EEG recording during single-pulse TMS to assess cortical excitability. The session will last approximately 60-90 minutes.

    Device: MRI · Device: HD-EEG Recording

Interventions

  • DeviceMRI

    All participants will undergo an MRI scan prior to the intervention to acquire T1-weighted images. MRI data will be provided by the Cook Children's Radiology Department. MRI scans will be used for neuronavigation.

  • DeviceHD-EEG Recording

    High-density EEG (HD-EEG) is a safe and non-invasive brain imaging technique. It involves placing a cap with small sensors on the child's head to measure the brain's electrical activity. This technique does not send any energy into the brain. The investigators will use the HD-EEG to measure motor-evoked potentials (MEPs) and TMS-evoked potentials (TEPs).

  • DevicerTMS

    rTMS is a safe, non-invasive way to map brain activity using gentle magnetic pulses. A small coil is placed near the head to stimulate nerve cells without any pain. This helps us understand how the brain controls movement.

06

What researchers measure

Primary outcomes

  1. Change on TMS-evoked potentials (TEPs)

    TEPs refer to the electrical responses in the brain elicited by rTMS. This technique involves applying magnetic pulses to specific brain areas, which induce electrical activity that can be recorded using EEG.

    Time frame: Within the end of 4 weeks and 1-month follow-up of sham/real rTMS

Secondary outcomes

  1. Change on cortical excitability - motor evoked potentials (MEPs)

    MEPs are electrical signals generated by stimulating the brain's motor cortex and recorded from muscles.

    Time frame: Within the end of 4 weeks and 1-month follow-up of sham/real rTMS

Other outcomes

  1. Modified Ashworth Scale (MAS)

    The Modified Ashworth Scale assesses spasticity in patients with central nervous system lesions or neurological disorders. It provides a rapid and straightforward method for clinicians to evaluate spasticity while performing passive soft-tissue stretches.

    Time frame: Within the end of 4 weeks and 1-month follow-up of sham/real rTMS

  2. Mirror Movement Assessment

    This evaluates the presence and severity of involuntary mirror movements, where movement in one limb is mirrored by involuntary movement in the opposite limb. It provides a structured approach to quantify and monitor these movements, helping to gauge the impact of therapeutic interventions and track changes over time.

    Time frame: Within the end of 4 weeks and 1-month follow-up of sham/real rTMS

  3. Gross Motor Function Measure (GMFM-88)

    It is a standardized observational tool specifically created and validated to assess changes in gross motor function over time in children with CP. The GMFM-88 allows for the summation of item scores to generate raw and percentage scores for each of the five GMFM dimensions, the selected goal areas, and an overall GMFM-88 score.

    Time frame: Within the end of 4 weeks and 1-month follow-up of sham/real rTMS

  4. Adverse effects

    Adverse effects of TMS-EEG can include temporary headaches, scalp discomfort, and mild skin irritation from EEG electrodes. Rarely, individuals might experience transient cognitive effects or muscle twitching. There is also a minimal risk of inducing seizures, particularly in those with a history of epilepsy.

    Time frame: Within the end of 4 weeks and 1-month follow-up of sham/real rTMS

  5. Finger Tapping Task

    A keyboard tapping task measuring low-level motor ability and psychomotor speed. Modeled after the Finger Tapping or Oscillation task from the Reitan Test Battery. Participants tap a key as quickly as possible for multiple trials, testing dominant and/or non-dominant hand.

    Time frame: Within the end of 4 weeks and 1-month follow-up of sham/real rTMS

  6. Task Fitt's Law Task

    Classic motor control task measuring the speed-accuracy tradeoff in rapid aimed movements. Tests the relationship between movement time, distance, and target size, following Fitts' Law (MT = a + b\*log2(2D/W)). Participants rapidly move the mouse cursor from a home position to rectangular targets of varying sizes and distances. Each trial begins at the home position on the left side of the screen. When ready, participants move to the target rectangle as quickly as possible. Movement time and accuracy are recorded for each trial.

    Time frame: Within the end of 4 weeks and 1-month follow-up of sham/real rTMS

  7. Pursuit Rotor

    Motor tracking task requiring continuous tracking of a moving target with mouse or touch input. Measures motor coordination and learning.

    Time frame: Within the end of 4 weeks and 1-month follow-up of sham/real rTMS

  8. Time Tapping Task

    Motor timing task measuring self-paced tapping consistency across multiple trials. Participants tap at a self-paced even rate following a visual entrainment period. After seeing a flashing cross that demonstrates the target tapping rate, participants must maintain that rhythm for a sustained period (default 180 seconds per trial). The task assesses low-level motor timing ability and may be sensitive to fatigue, sleep deprivation, and motor control deficits.

    Time frame: Within the end of 4 weeks and 1-month follow-up of sham/real rTMS

  9. Simple Reaction Time

    A simple reaction time task where a single stimulus (an 'X' or mouse button prompt) appears at a specifiable delay from the previous response. Measures basic alertness and motor response speed across multiple blocks with breaks.

    Time frame: Within the end of 4 weeks and 1-month follow-up of sham/real rTMS

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Mutanen TP, Biabani M, Sarvas J, Ilmoniemi RJ, Rogasch NC. Source-based artifact-rejection techniques available in TESA, an open-source TMS-EEG toolbox. Brain Stimul. 2020 Sep-Oct;13(5):1349-1351. doi: 10.1016/j.brs.2020.06.079. Epub 2020 Jul 10. No abstract available. PubMed 32659484 ↗
  • Rogasch NC, Sullivan C, Thomson RH, Rose NS, Bailey NW, Fitzgerald PB, Farzan F, Hernandez-Pavon JC. Analysing concurrent transcranial magnetic stimulation and electroencephalographic data: A review and introduction to the open-source TESA software. Neuroimage. 2017 Feb 15;147:934-951. doi: 10.1016/j.neuroimage.2016.10.031. Epub 2016 Oct 20. PubMed 27771347 ↗
  • Iversen, J. R. & Makeig, S. MEG/EEG data analysis using EEGLAB. Magnetoencephalography: From signals to dynamic cortical networks 391-406 (2019).
  • Tadel F, Baillet S, Mosher JC, Pantazis D, Leahy RM. Brainstorm: a user-friendly application for MEG/EEG analysis. Comput Intell Neurosci. 2011;2011:879716. doi: 10.1155/2011/879716. Epub 2011 Apr 13. PubMed 21584256 ↗
  • Croarkin PE, Wall CA, Lee J. Applications of transcranial magnetic stimulation (TMS) in child and adolescent psychiatry. Int Rev Psychiatry. 2011 Oct;23(5):445-53. doi: 10.3109/09540261.2011.623688. PubMed 22200134 ↗
  • Gilbert DL, Garvey MA, Bansal AS, Lipps T, Zhang J, Wassermann EM. Should transcranial magnetic stimulation research in children be considered minimal risk? Clin Neurophysiol. 2004 Aug;115(8):1730-9. doi: 10.1016/j.clinph.2003.10.037. PubMed 15261851 ↗
  • Zewdie E, Ciechanski P, Kuo HC, Giuffre A, Kahl C, King R, Cole L, Godfrey H, Seeger T, Swansburg R, Damji O, Rajapakse T, Hodge J, Nelson S, Selby B, Gan L, Jadavji Z, Larson JR, MacMaster F, Yang JF, Barlow K, Gorassini M, Brunton K, Kirton A. Safety and tolerability of transcranial magnetic and direct current stimulation in children: Prospective single center evidence from 3.5 million stimulations. Brain Stimul. 2020 May-Jun;13(3):565-575. doi: 10.1016/j.brs.2019.12.025. Epub 2019 Dec 30. PubMed 32289678 ↗
  • Lerner AJ, Wassermann EM, Tamir DI. Seizures from transcranial magnetic stimulation 2012-2016: Results of a survey of active laboratories and clinics. Clin Neurophysiol. 2019 Aug;130(8):1409-1416. doi: 10.1016/j.clinph.2019.03.016. Epub 2019 Apr 6. PubMed 31104898 ↗
  • Canadian Occupational Performance Measure (COPM) http://www.thecopm.ca/
  • Jebsen-Taylor Hand Function Test (JHFT): http://www.strokengine.ca/assess/jhft/
  • Melbourne Assessment of Unilateral Upper Limb Function (MUUL): Access can be found at http://www.rch.org.au/melbourneassessment/
  • Assessment of Motor and Process Skills (AMPS): Access can be found at http://www.innovativeotsolutions.com/content/amps/
  • Manual Ability Classification System (MACS) http://www.macs.nu/
  • Krumlinde-Sundholm, L. & Eliasson, A.-C. Development of the Assisting Hand Assessment: a Rasch-built measure intended for children with unilateral upper limb impairments. Scand J Occup Ther 10, 16-26 (2003).
  • Harb A, Margetis K, Kishner S. Modified Ashworth Scale. 2025 Apr 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK554572/ PubMed 32119459 ↗
  • Russell, D. J., Rosenbaum, P., Wright, M. & Avery, L. M. Gross Motor Function Measure (GMFM-66 & GMFM-88) Users Manual. (Mac keith press, 2002).
  • Rosenbaum PL, Palisano RJ, Bartlett DJ, Galuppi BE, Russell DJ. Development of the Gross Motor Function Classification System for cerebral palsy. Dev Med Child Neurol. 2008 Apr;50(4):249-53. doi: 10.1111/j.1469-8749.2008.02045.x. Epub 2008 Mar 1. PubMed 18318732 ↗
  • Jung SH, Shin JE, Jeong YS, Shin HI. Changes in motor cortical excitability induced by high-frequency repetitive transcranial magnetic stimulation of different stimulation durations. Clin Neurophysiol. 2008 Jan;119(1):71-9. doi: 10.1016/j.clinph.2007.09.124. Epub 2007 Nov 26. PubMed 18039593 ↗
  • Gillick BT, Krach LE, Feyma T, Rich TL, Moberg K, Thomas W, Cassidy JM, Menk J, Carey JR. Primed low-frequency repetitive transcranial magnetic stimulation and constraint-induced movement therapy in pediatric hemiparesis: a randomized controlled trial. Dev Med Child Neurol. 2014 Jan;56(1):44-52. doi: 10.1111/dmcn.12243. Epub 2013 Aug 21. PubMed 23962321 ↗
  • Todd G, Flavel SC, Ridding MC. Priming theta-burst repetitive transcranial magnetic stimulation with low- and high-frequency stimulation. Exp Brain Res. 2009 May;195(2):307-15. doi: 10.1007/s00221-009-1791-8. Epub 2009 Apr 11. PubMed 19363604 ↗
  • Carey JR, Anderson DC, Gillick BT, Whitford M, Pascual-Leone A. 6-Hz primed low-frequency rTMS to contralesional M1 in two cases with middle cerebral artery stroke. Neurosci Lett. 2010 Jan 29;469(3):338-42. doi: 10.1016/j.neulet.2009.12.023. Epub 2009 Dec 18. PubMed 20026185 ↗
  • Kakuda W, Abo M, Kobayashi K, Momosaki R, Yokoi A, Fukuda A, Umemori T. Application of combined 6-Hz primed low-frequency rTMS and intensive occupational therapy for upper limb hemiparesis after stroke. NeuroRehabilitation. 2011;29(4):365-71. doi: 10.3233/NRE-2011-0714. PubMed 22207064 ↗
  • Tallabs FA, Hammond-Tooke GD. Theta priming of 1-Hz rTMS in healthy volunteers: effects on motor inhibition. J Clin Neurophysiol. 2013 Feb;30(1):79-85. doi: 10.1097/WNP.0b013e31827ed0e3. PubMed 23377446 ↗
  • Cassidy JM, Chu H, Anderson DC, Krach LE, Snow L, Kimberley TJ, Carey JR. A Comparison of Primed Low-frequency Repetitive Transcranial Magnetic Stimulation Treatments in Chronic Stroke. Brain Stimul. 2015 Nov-Dec;8(6):1074-84. doi: 10.1016/j.brs.2015.06.007. Epub 2015 Jun 22. PubMed 26198365 ↗
  • Rajak BL, Gupta M, Bhatia D, Mukherjee A. Increasing Number of Therapy Sessions of Repetitive Transcranial Magnetic Stimulation Improves Motor Development by Reducing Muscle Spasticity in Cerebral Palsy Children. Ann Indian Acad Neurol. 2019 Jul-Sep;22(3):302-307. doi: 10.4103/aian.AIAN_102_18. PubMed 31359942 ↗
  • Lee JC, Wilson AC, Corlier J, Tadayonnejad R, Marder KG, Pleman CM, Krantz DE, Wilke SA, Levitt JG, Ginder ND, Leuchter AF. Strategies for augmentation of high-frequency left-sided repetitive transcranial magnetic stimulation treatment of major depressive disorder. J Affect Disord. 2020 Dec 1;277:964-969. doi: 10.1016/j.jad.2020.09.011. Epub 2020 Sep 8. PubMed 33065840 ↗
  • Gupta J, Gulati S, Singh UP, Kumar A, Jauhari P, Chakrabarty B, Pandey RM, Bhatia R, Jain S, Srivastava A. Brain Stimulation and Constraint Induced Movement Therapy in Children With Unilateral Cerebral Palsy: A Randomized Controlled Trial. Neurorehabil Neural Repair. 2023 May;37(5):266-276. doi: 10.1177/15459683231174222. Epub 2023 May 11. PubMed 37170480 ↗
  • Barr MS, Farzan F, Davis KD, Fitzgerald PB, Daskalakis ZJ. Measuring GABAergic inhibitory activity with TMS-EEG and its potential clinical application for chronic pain. J Neuroimmune Pharmacol. 2013 Jun;8(3):535-46. doi: 10.1007/s11481-012-9383-y. Epub 2012 Jun 29. PubMed 22744222 ↗
  • Pellicciari MC, Veniero D, Miniussi C. Characterizing the Cortical Oscillatory Response to TMS Pulse. Front Cell Neurosci. 2017 Feb 27;11:38. doi: 10.3389/fncel.2017.00038. eCollection 2017. No abstract available. PubMed 28289376 ↗
  • Massimini M, Tononi G, Huber R. Slow waves, synaptic plasticity and information processing: insights from transcranial magnetic stimulation and high-density EEG experiments. Eur J Neurosci. 2009 May;29(9):1761-70. doi: 10.1111/j.1460-9568.2009.06720.x. Epub 2009 Apr 27. PubMed 19473231 ↗
  • Ilmoniemi RJ, Kicic D. Methodology for combined TMS and EEG. Brain Topogr. 2010 Jan;22(4):233-48. doi: 10.1007/s10548-009-0123-4. Epub 2009 Dec 10. PubMed 20012350 ↗
  • Thut G, Pascual-Leone A. A review of combined TMS-EEG studies to characterize lasting effects of repetitive TMS and assess their usefulness in cognitive and clinical neuroscience. Brain Topogr. 2010 Jan;22(4):219-32. doi: 10.1007/s10548-009-0115-4. Epub 2009 Oct 28. PubMed 19862614 ↗
  • Daskalakis ZJ, Farzan F, Radhu N, Fitzgerald PB. Combined transcranial magnetic stimulation and electroencephalography: its past, present and future. Brain Res. 2012 Jun 29;1463:93-107. doi: 10.1016/j.brainres.2012.04.045. Epub 2012 Apr 28. PubMed 22608075 ↗
  • Abraham WC, Bear MF. Metaplasticity: the plasticity of synaptic plasticity. Trends Neurosci. 1996 Apr;19(4):126-30. doi: 10.1016/s0166-2236(96)80018-x. PubMed 8658594 ↗
  • Kirton A. Modeling developmental plasticity after perinatal stroke: defining central therapeutic targets in cerebral palsy. Pediatr Neurol. 2013 Feb;48(2):81-94. doi: 10.1016/j.pediatrneurol.2012.08.001. PubMed 23337000 ↗
  • Naeser MA, Martin PI, Nicholas M, Baker EH, Seekins H, Helm-Estabrooks N, Cayer-Meade C, Kobayashi M, Theoret H, Fregni F, Tormos JM, Kurland J, Doron KW, Pascual-Leone A. Improved naming after TMS treatments in a chronic, global aphasia patient--case report. Neurocase. 2005 Jun;11(3):182-93. doi: 10.1080/13554790590944663. PubMed 16006338 ↗
  • Gupta, M., Rajak, B. L., Bhatia, D. & Mukherjee, A. Effect of repetitive transcranial magnetic stimulation on motor function and spasticity in spastic cerebral palsy. Int J Biomed Eng Technol 31, 365-374 (2019).
  • Elbanna ST, Elshennawy S, Ayad MN. Noninvasive Brain Stimulation for Rehabilitation of Pediatric Motor Disorders Following Brain Injury: Systematic Review of Randomized Controlled Trials. Arch Phys Med Rehabil. 2019 Oct;100(10):1945-1963. doi: 10.1016/j.apmr.2019.04.009. Epub 2019 May 10. PubMed 31078616 ↗
  • Casanova MF, Shaban M, Ghazal M, El-Baz AS, Casanova EL, Opris I, Sokhadze EM. Effects of Transcranial Magnetic Stimulation Therapy on Evoked and Induced Gamma Oscillations in Children with Autism Spectrum Disorder. Brain Sci. 2020 Jul 3;10(7):423. doi: 10.3390/brainsci10070423. PubMed 32635201 ↗
  • Pascual-Leone A, Amedi A, Fregni F, Merabet LB. The plastic human brain cortex. Annu Rev Neurosci. 2005;28:377-401. doi: 10.1146/annurev.neuro.27.070203.144216. PubMed 16022601 ↗
  • Chung MG, Lo WD. Noninvasive brain stimulation: the potential for use in the rehabilitation of pediatric acquired brain injury. Arch Phys Med Rehabil. 2015 Apr;96(4 Suppl):S129-37. doi: 10.1016/j.apmr.2014.10.013. Epub 2014 Nov 6. PubMed 25448248 ↗
  • Kirton A. Advancing non-invasive neuromodulation clinical trials in children: Lessons from perinatal stroke. Eur J Paediatr Neurol. 2017 Jan;21(1):75-103. doi: 10.1016/j.ejpn.2016.07.002. Epub 2016 Jul 9. PubMed 27470654 ↗
  • Hameed MQ, Dhamne SC, Gersner R, Kaye HL, Oberman LM, Pascual-Leone A, Rotenberg A. Transcranial Magnetic and Direct Current Stimulation in Children. Curr Neurol Neurosci Rep. 2017 Feb;17(2):11. doi: 10.1007/s11910-017-0719-0. PubMed 28229395 ↗
  • Azizi S, Marzbani H, Raminfard S, Birgani PM, Rasooli AH, Mirbagheri MM. The impact of an anti-gravity treadmill (AlterG) training on walking capacity and corticospinal tract structure in children with cerebral palsy. Annu Int Conf IEEE Eng Med Biol Soc. 2017 Jul;2017:1150-1153. doi: 10.1109/EMBC.2017.8037033. PubMed 29060079 ↗
  • Takeuchi N, Oouchida Y, Izumi S. Motor control and neural plasticity through interhemispheric interactions. Neural Plast. 2012;2012:823285. doi: 10.1155/2012/823285. Epub 2012 Dec 26. PubMed 23326685 ↗
  • Cox BC, Cincotta M, Espay AJ. Mirror movements in movement disorders: a review. Tremor Other Hyperkinet Mov (N Y). 2012;2:tre-02-59-398-1. doi: 10.7916/D8VQ31DZ. Epub 2012 Apr 16. PubMed 23440079 ↗
  • Fling BW, Seidler RD. Task-dependent effects of interhemispheric inhibition on motor control. Behav Brain Res. 2012 Jan 1;226(1):211-7. doi: 10.1016/j.bbr.2011.09.018. Epub 2011 Sep 16. PubMed 21944939 ↗
  • Kuo HC, Ferre CL, Chin KY, Friel KM, Gordon AM. Mirror movements and brain pathology in children with unilateral cerebral palsy. Dev Med Child Neurol. 2023 Feb;65(2):264-273. doi: 10.1111/dmcn.15322. Epub 2022 Jun 24. PubMed 35751166 ↗
  • Yeargin-Allsopp M, Van Naarden Braun K, Doernberg NS, Benedict RE, Kirby RS, Durkin MS. Prevalence of cerebral palsy in 8-year-old children in three areas of the United States in 2002: a multisite collaboration. Pediatrics. 2008 Mar;121(3):547-54. doi: 10.1542/peds.2007-1270. PubMed 18310204 ↗
  • Stanley, F. J., Blair, E., Alberman, E. & Alberman, E. D. Cerebral Palsies: Epidemiology and Causal Pathways. (Cambridge University Press, 2000).
  • Diego, A. & Leung, A. Transcranial direct current stimulation for improving gross motor function in children with cerebral palsy: A systematic review. British Journal of Occupational Therapy 83, 030802261989788 (2020).
  • Bar-On L, Molenaers G, Aertbelien E, Van Campenhout A, Feys H, Nuttin B, Desloovere K. Spasticity and its contribution to hypertonia in cerebral palsy. Biomed Res Int. 2015;2015:317047. doi: 10.1155/2015/317047. Epub 2015 Jan 11. PubMed 25649546 ↗
  • Green LB, Hurvitz EA. Cerebral palsy. Phys Med Rehabil Clin N Am. 2007 Nov;18(4):859-82, vii. doi: 10.1016/j.pmr.2007.07.005. PubMed 17967366 ↗
  • Reddihough D. Cerebral palsy in childhood. Aust Fam Physician. 2011 Apr;40(4):192-6. PubMed 21597527 ↗
  • Chen, X. J. & Li, S. C. Definition, classification and diagnostic conditions of cerebral palsy in children. Chinese Journal of Physical Medicine and Rehabilitation 29, 309 (2007).
  • Hayes C. Cerebral palsy: classification, diagnosis and challenges of care. Br J Nurs. 2010 Mar 25-Apr 7;19(6):368-73. doi: 10.12968/bjon.2010.19.6.47249. PubMed 20335916 ↗
  • Colver A, Fairhurst C, Pharoah PO. Cerebral palsy. Lancet. 2014 Apr 5;383(9924):1240-9. doi: 10.1016/S0140-6736(13)61835-8. Epub 2013 Nov 20. PubMed 24268104 ↗
  • Gupta M, Rajak BL, Bhatia D, Mukherjee A. Neuromodulatory effect of repetitive transcranial magnetic stimulation pulses on functional motor performances of spastic cerebral palsy children. J Med Eng Technol. 2018 Jul;42(5):352-358. doi: 10.1080/03091902.2018.1510555. Epub 2018 Sep 3. PubMed 30175934 ↗
  • Sun YY, Wang L, Peng JL, Huang YJ, Qiao FQ, Wang P. Effects of repetitive transcranial magnetic stimulation on motor function and language ability in cerebral palsy: A systematic review and meta-analysis. Front Pediatr. 2023 Feb 16;11:835472. doi: 10.3389/fped.2023.835472. eCollection 2023. PubMed 36873646 ↗
  • Soleimani F, Vameghi R, Biglarian A. Antenatal and intrapartum risk factors for cerebral palsy in term and near-term newborns. Arch Iran Med. 2013 Apr;16(4):213-6. PubMed 23496363 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for May 2028, 23 months after the start.

Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 23 months is above that.

Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 28, 2026
First posted
May 5, 2026
StartActual
May 27, 2026
Primary completionEst.
May 1, 2028
CompletionEst.
Jun 1, 2030
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 22, 2026
Sites
Cook Children's Hospital is now Recruiting
Oct 22, 2026
Start date
May 1, 2026→May 27, 2026 (actual)
Oct 22, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Cook Children's Hospital · Fort Worth, United StatesContact C•••@cookchilrens.org · •••3236→C•••@cookchilrens.org · •••3236
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    Not yet recruiting→Recruiting
    Cook Children's Hospital is now Recruiting
    Start date May 1, 2026→May 27, 2026 (now actual)
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Cook Children's Hospital · Fort Worth, United StatesContact C•••@cookchilrens.org · •••3236→C•••@cookchilrens.org · •••3236
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07567053
Lead sponsor
Cook Children's Health Care System
Responsible party
Sponsor
First posted
May 5, 2026
Start date
May 27, 2026
Primary completion
May 1, 2028 (estimated)
Completion
Jun 1, 2030 (estimated)
Last update
Oct 22, 2026

Study contacts

Christos Papadelis, PhD
Contact
Christos.Papadelis@cookchildrens.org
682-305-3236
Behnam Ghabel Damirchi, MSc
Contact
behnam.ghabeldamirchi@cookchildrens.org
682-367-3956
Christos Papadelis, PhD
principal investigator · Cook Children's Health Care System

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion